JAYASHREE JOHN: Open Payments
NPI 1003012915 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 24 payments from 10 companies in 2025. Trend: 2023 $401 · 2024 $262 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $131 |
| ABBVIE INC. | 4 | $76 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Biogen, Inc. | 1 | $23 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
Products named: AUSTEDO XR, VRAYLAR, INGREZZA, TRINTELLIX, ARISTADA, SPRAVATO, COBENFY, ABILIFY MAINTENA.
Industry payments across GA — which companies pay providers there.
